---
title: "Anteris Wins Court Relief on Late Cleansing Notice, Trading Halt Set to Lift"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294664311.md"
description: "Anteris Technologies secured Federal Court relief for a late cleansing notice, validating past securities transactions and removing civil liability risks. Consequently, the company requested the ASX lift its trading halt effective August 2, 2026. This ruling provides legal certainty and limits market disruption. The stock currently holds a 'Buy' rating with an A$13.00 price target."
datetime: "2026-08-03T08:39:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294664311.md)
  - [en](https://longbridge.com/en/news/294664311.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294664311.md)
generator: "portal-rs"
---

# Anteris Wins Court Relief on Late Cleansing Notice, Trading Halt Set to Lift

Anteris Technologies ( (AU:AVR) ) has shared an announcement.

Anteris Technologies Global Corp. has secured Federal Court of Australia orders rectifying an administrative oversight related to the late lodgement of a cleansing notice for 44,068 CHESS Depositary Interests issued on 10 July 2026. The court extended the statutory period for the notice, deemed the notice effective from the issue date, and confirmed that past offers or sales of the affected securities are not invalid.

The ruling also relieves investors who received and on-sold the impacted CDIs from potential civil liability tied to the disclosure lapse, providing legal certainty for recent transactions in the company’s securities. With the court relief granted, Anteris has asked the ASX to lift the trading halt on its shares from market open on 4 August 2026, limiting disruption to trading and reinforcing compliance confidence for shareholders and market participants.

The most recent analyst rating on (AU:AVR) stock is a Buy  
 with a A$13.00 price target.  
 To see the full list of analyst forecasts on Anteris Technologies stock,  
 see the AU:AVR Stock Forecast page. 

**More about Anteris Technologies**

Anteris Technologies Global Corp. is a dual-listed medical technology company trading on Nasdaq and the ASX, operating from hubs in Brisbane and Minneapolis. The company focuses on advanced cardiovascular solutions and related life sciences technologies, targeting global healthcare markets through its presence in North America, Europe and Australia.

**Average Trading Volume:** 26,312

**Technical Sentiment Signal:** Sell

**Current Market Cap:** A$1.1B

For a thorough assessment of AVR stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [AVR.US](https://longbridge.com/en/quote/AVR.US.md)
- [AVR.AU](https://longbridge.com/en/quote/AVR.AU.md)

## Related News & Research

- [L1 Capital Pty Ltd Sells 558,633 Shares of Anteris Technologies Global (NASDAQ:AVR) Stock](https://longbridge.com/en/news/294503402.md)
- [L1 Capital reports $4.11 million Anteris Technologies share disposal](https://longbridge.com/en/news/295093404.md)
- [Femto Technologies reports Q2 results](https://longbridge.com/en/news/296650988.md)
- [A $350 Million Reason to Buy HIVE Digital Technologies Stock](https://longbridge.com/en/news/296392218.md)
- [LHX Stock in Focus as L3Harris Technologies Ousts CEO](https://longbridge.com/en/news/296270949.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**